{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T07:15:08Z","timestamp":1649056508445},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.6122","type":"journal-article","created":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T22:05:47Z","timestamp":1463263547000},"page":"1351-1354","source":"Crossref","is-referenced-by-count":3,"title":["Anti-myelin Oligodendrocyte Glycoprotein Antibodies in a Patient with Recurrent Optic Neuritis Involving the Cerebral White Matter and Brainstem"],"prefix":"10.2169","volume":"55","author":[{"given":"Tadashi","family":"Adachi","sequence":"first","affiliation":[{"name":"Division of Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Yasui","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yonezawa National Hospital, Japan"},{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Fujihara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Rostasy K, Reindl M. Role of autoantibodies in acquired inflammatory demyelinating diseases of the central nervous system in children. Neuropediatrics 44: 297-301, 2013.","DOI":"10.1055\/s-0033-1358602"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Baumann M, Sahin K, Lechner C, et al. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein. J Neurol Neurosurg Psychiatry 86: 265-272, 2015.","DOI":"10.1136\/jnnp-2014-308346"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kitley J, Woodhall M, Waters P, et al. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 79: 1273-1277, 2012.","DOI":"10.1212\/WNL.0b013e31826aac4e"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kitley J, Waters P, Woodhall M, et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol 71: 276-283, 2014.","DOI":"10.1001\/jamaneurol.2013.5857"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sato DK, Callegaro D, Lana-Peixoto MA, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 82: 474-481, 2014.","DOI":"10.1212\/WNL.0000000000000101"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nakajima H, Motomura M, Tanaka K, et al. Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis. BMJ Open 5: e007766, 2015.","DOI":"10.1136\/bmjopen-2015-007766"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sato DK, Nakashima I, Takahashi T, et al. Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. Neurology 80: 2210-2216, 2013.","DOI":"10.1212\/WNL.0b013e318296ea08"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol 6: 805-815, 2007.","DOI":"10.1016\/S1474-4422(07)70216-8"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Amano H, Miyamoto N, Shimura H, et al. Influenza-associated MOG antibody-positive longitudinally extensive transverse myelitis: a case report. BMC Neurol 14: 224, 2014.","DOI":"10.1186\/s12883-014-0224-x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Brunner C, Lassmann H, Waehneldt TV, Matthieu JM, Linington C. Differential ultrastructural localization of myelin basic protein, myelin\/oligodendroglial glycoprotein, and 2',3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats. J Neurochem 52: 296-304, 1989.","DOI":"10.1111\/j.1471-4159.1989.tb10930.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Reindl M, Di Pauli F, Rostasy K, Berger T. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol 9: 455-461, 2013.","DOI":"10.1038\/nrneurol.2013.118"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Misu T, Sato DK, Nakashima I, Fujihara K. MOG-IgG serological status matters in paediatric ADEM. J Neurol Neurosurg Psychiatry 86: 242, 2015.","DOI":"10.1136\/jnnp-2014-308723"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kezuka T, Tanaka K, Matsunaga Y, Goto H. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 83: 475, 2014.","DOI":"10.1212\/WNL.0000000000000636"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85: 177-189, 2015.","DOI":"10.1212\/WNL.0000000000001729"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/10\/55_55.6122\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T13:42:12Z","timestamp":1498311732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/10\/55_55.6122\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.6122","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}